#Spain #Barcelona #Probiotics #Health #BioFlag

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

On May 20, 2025, at the esteemed Vitafoods Europe event held in Barcelona, BioFlag Co., Ltd. (Bioflag), a prominent Chinese leader in the field of probiotics, proudly revealed its scientifically validated functional probiotic solutions. These sustainable solutions aim to capture the attention of international media and the health-conscious audience.

During the event, BioFlag presented a range of their cutting-edge products, which include clinically proven probiotic strains and finished probiotic products aimed at various health benefits. These benefits encompass intestinal health, immune regulation, metabolic health, weight management, oral health, and emotional well-being. Furthermore, the company introduced customized probiotic solutions, engineered to meet the strictest standards in both Europe and the United States.

Key Innovations Unveiled

The company's standout innovations featured at the event include:

• - Bifidobacterium animalis subsp. lactis BL-99: Originating from Bioflag's proprietary library of maternal-infant probiotics, BL-99 is the foundation for 12 Chinese patents concerning intestinal health, immune regulation, and bone health. It's widely utilized in infant formulas, yogurts, and dietary supplements.
• - Lactobacillus paracasei K56: Isolated from the intestines of healthy Chinese infants, this strain has been clinically proven to reduce body fat, visceral fat, and waist circumference. It is supported by 12 published studies and is covered by 9 patents in China.
• - Bifidobacterium animalis subsp. lactis CP-9: Derived from the breast milk of healthy Chinese mothers, CP-9 is patented in China for its anti-obesity effects and its role in treating or preventing jaundice.

As a representative of the Chinese probiotic industry, Bioflag demonstrated its capabilities across the entire industrial chain, boasting:

• - An exclusive library of over 3,500 strains and more than 30 functional screening platforms.
• - More than 130 issued patents and over 100 published scientific papers.
• - International certifications like GMP, FSSC22000, and HALAL.
• - The capability to manufacture powders, tablets, capsules, and other dosage forms.

Strategic Partnerships Formed

At the exhibition, Bioflag successfully sealed cooperation agreements with dozens of businesses and institutions from Europe, North America, and beyond. A spokesperson for the company remarked, “With nearly two decades of expertise in the functional probiotic field, we are committed to driving innovation in R&D and smart manufacturing, aiming to provide superior health solutions to our global customers.”

For more detailed information about their offerings, interested parties can visit Bioflag's official website.

The presence of Bioflag at Vitafoods Europe 2025 signifies not only the company’s growth and ambition but also its commitment to improving health outcomes through innovative probiotic solutions.